Course Information

UCLA Heart Failure Symposium 2021: State-of-the-Art Updates & Therapies for Advanced Heart Failure

Live In-Person & Live Virtual Learning
The Ritz-Carlton, Marina del Rey
Marina del Rey, California

September 18, 2021

*Please note that the course syllabus will be available online only to registered attendees.
A password link will be sent prior to the course.

Syllabus for Conference Registrants

Download: [ PDF ]

Heart failure affects approximately six million Americans and is the most common diagnosis for acute hospitalization in patients over 65 years. Over the next decade, we will see a dramatic increase in the number of patients in the community with advanced heart failure who can benefit from advanced therapies for complex cardiac disease. Academic medical centers, such as UCLA, have an opportunity to integrate treatment advances into a comprehensive patient-centered heart failure management program. UCLA Health wants to enhance the role of the primary care physician and primary cardiologist as the central provider for continuity of care for these complex heart failure patients.

The Ninth Annual UCLA Heart Failure Symposium 2021 will:

  • Discuss general heart failure treatment options including short and long term mechanical circulatory support therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous and structural interventions, and complex congenital heart disease management.
  • Emphasize the need for developing networks linking academic centers with community physicians to manage these patients through the evolution of their disease pre and post advanced cardiac intervention.
  • Discuss heart failure therapies in cardio-oncology, amyloidosis and new medication updates, as well as address patient and care-provider’s specific needs and perspectives.

Target Audience

Family practitioners, internists, cardiologists, pediatricians, nurses and all other healthcare professionals taking care of heart failure patients, as well as the interested lay public.

General Information

In-person attendees will be provided breakfast, patio lunch, and reception at the meeting site.

The UCLA Heart Failure Symposium 2021 will also be available through a live virtual meeting web platform.

  • Attendees who choose to attend the live virtual activity will receive a virtual meeting link and password to access the live virtual conference.
  • All registrants (live or virtual) will be provided the opportunity to review recorded sessions up to 3 weeks following the conference.
  • Attendees will be awarded CME credit commensurate with the extent of their participation in the live activity (either in-person or virtual). The recorded sessions are not certified for CME credit.

If the in-person gathering is canceled or capacity limits modified per CDC or public health guidelines, the Heart Failure conference will be modified accordingly, or presented entirely as a live virtual activity.

Enrollment

The in-person capacity for this conference has been reached. If you would still like to attend this conference virtually, please register below.

To enroll click here.

*Note: To ensure course material is received before the course begins, early registration is advised. Online registration will close at 11:59 PM on Thursday, September 16th.

Enrollment after online registration has closed:

  • Option 1: Please call (310) 794 – 2620 between 8:00 AM – 5:00 PM (Pacific Standard Time) by Friday, September 17th.
  • Option 2: Email us between 8:00 AM – 5:00 PM (Pacific Standard Time) at UCLACME@mednet.ucla.edu by Friday, September 17th.

Enrollment on the day of the courseIf you would like to register for the virtual Heart Failure conference, please call (512) 270-8113 to enroll.

Course Fees

  • Live Virtual: $75
  • Live In-Person: $75
    • On-site registration will be available

Refunds

Pre-registration fee is non-refundable.

David Geffen School of Medicine at UCLA

COURSE CHAIR
Ali Nsair, MD
Medical Director, Heart Transplantation and Mechanical Circulatory Support Device Services
Heart Failure
Interventional Cardiology
Broad Stem Cell Research Center

UCLA COURSE FACULTY AND PANEL PARTICIPANTS
Jamil Aboulhosn, MD, FACC
Professor of Clinical Medicine and Pediatrics
Director, Ahmanson/UCLA Adult Congenital Heart Disease Center

Olcay Aksoy, MD, FACC
Assistant Clinical Professor
Interventional Cardiology
UCLA Cardiovascular Medicine

Abbas Ardehali, MD, FACS
Professor of Surgery and Medicine
Division of Cardiothoracic Surgery
William E. Connor Chair in Cardiothoracic Transplantation
Director, UCLA Heart, Lung, and Heart-Lung Transplant Programs

Arnold S. Baas, MD, FACC, FACP
Professor of Medicine
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Jason Bradfield, MD, FACC, FHRS
Associate Professor of Medicine
Director, Specialized Program for Ventricular Tachycardia
UCLA Cardiac Arrhythmia Center

Marcella Calfon-Press, MD, PhD, FACC
Assistant Clinical Professor
Interventional Cardiology
Co-Director, UCLA Barbra Streisand Women’s Heart Health Program
Associate Program Director, Interventional Cardiology Fellowship

Julie W. Creaser, RN, MN, CNS, CHFN
Advanced Practice Nurse, Ahmanson-UCLA Cardiomyopathy Center

Daniel Cruz, MD, PhD
Associate Clinical Professor of Medicine
Associate Director, Heart Transplant
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Ravi H. Dave, MD
Director of Interventional Cardiology at UCLA Health
Program Director of the Interventional Cardiology Fellowship Program
Director of the Cardiac Catheterization Laboratories
Santa Monica UCLA Medical Center and Community Cardiology Practices

Mario Deng, MD, FACC, FESC
Professor of Medicine
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Gregg C. Fonarow, MD, FACC, FAHA, FHFSA
Chief, UCLA Division of Cardiology
Director, Ahmanson-UCLA Cardiomyopathy Center
Co-Director, UCLA Preventative Cardiology Program
The Eliot Corday Chair in Cardiovascular Medicine and Science

Janet K. Han, MD, FACC, FHRS
Associate Professor of Medicine
Assistant Director, Cardiac Arrhythmia Service, VAGLAHS
Associate Program Director, Fellowship in Cardiovascular Diseases

Jeff Hsu, MD, PhD
Cardiology Fellow
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Megan Kamath, MD
Assistant Clinical Professor of Medicine
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Aaron Kaye, RN, BSN, CCRN
UCLA Outreach Coordinator for Advanced Cardiac Therapies

Murray H. Kwon, MD, MBA
Associate Clinical Professor
UCLA Division of Cardiac Surgery

Cathy Levenstein, LCSW
Clinical Social Worker
UCLA Advance Care Planning & Palliative Care
Department of Care Coordination and Clinical Social Work

Melissa A Moore, RN, MPH, CCTC
UCLA Heart and Lung Transplant Nurse Manager
Rushi Parikh, MD, FACC, FSCAI
Assistant Clinical Professor
Interventional Cardiology, Advanced Heart Failure
David Geffen School of Medicine at UCLA

Anca Rahman, RN, MSN, NP-C
Advanced Practice Nurse
Ahmanson-UCLA Cardiomyopathy Center

Rajan Saggar, MD
Associate Professor of Medicine
Director, Medical Intensive Care Unit
Lung and Heart-Lung Transplant and Pulmonary Hypertension Programs

Richard J. Shemin, MD, FACC
Robert and Kelly Day Professor and Chief Cardiothoracic Surgery
UCLA Executive Vice Chairman of Surgery
Co-Director of the Cardiovascular Center

Emily Stimpson, RN, MSN, CCTC
UCLA Transplant Call Team Manager

Kleanthis Theodoropoulos, MD
Cardiology Fellow
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Darko Vucicevic, MD
Ahmanson-UCLA Cardiomyopathy Center
Mechanical Circulatory Support and Heart Transplantation Program

Eric H. Yang, MD, FACC, FASE
Associate Clinical Professor of Medicine
Director, UCLA Cardio-Oncology Program
Associate Program Director
UCLA/Olive View/West LA VA Cardiovascular Diseases Fellowship
David Geffen School of Medicine at UCLA

Saturday, September 18, 2021

7:45 am (PST) Welcome and Introduction
Ali Nsair, MD
ADVANCED HEART FAILURE: Management and Treatment Updates
Moderators: Julie Creaser, RN, MN, CNS, CHFN and Kleanthis Theodoropoulos, MD
8:00 am State of the Art Medical Therapies in Advanced Heart Failure: What is New in 2021
Gregg Fonarow, MD, FACC,FAHA, FHFSA
8:20 am Heart & Heart-Lung Transplantation Updates
Abbas Ardehali, MD, FACS
8:40 am Working in Sync: Device Therapy and Arrhythmia Management
Jason Bradfield, MD
9:00 am Pulmonary Hypertension Management: From Surgical Interventions to Medical Therapies
Rajan Saggar, MD
9:20 am Cardiac Amyloidosis and the Evolution of Treatment Options
Megan Kamath, MD
9:40 am Patient Selection for Advanced Therapies in Heart Failure
Arnold Baas, MD, FACC, FACP
10:00 am Break
STRUCTURAL INTERVENTIONS AND MECHANICAL CIRCULATORY SUPPORT THERAPIES: State-of-the-Art Advancements
Moderators: Rushi Parikh, MD and Emily Stimpson, RN, MSN, CCTC
10:20 am Durable Left Ventricular Assist Devices, Current Therapies and New Advancements
Murray Kwon, MD, MBA
10:40 am Minimally Invasive Surgical interventions for Valvular Heart Disease: Robotics and Beyond
Richard Shemin, MD, FACC
11:00 am Functional & Degenerative Mitral Regurgitation: MitraClip and New Therapies
Marcella Calfon-Press, MD, PhD, FACC
11:20 am Aortic Stenosis in the Era of Low Risk TAVR: Updates and Future Directions in Heart Failure Patients
Olcay Aksoy, MD, FACC
11:40 am Adult Congenital Heart Disease Management: Medical Therapies and Structural Interventions
Jamil Aboulhosn, MD, FACC
12:00 pm When is Revascularization Complete: PCI in Multi-vessel Coronary Artery Disease
Ravi Dave, MD
12:20 pm Cardiogenic Shock: The Rising Role of Temporary Mechanical Circulatory Support
Ali Nsair, MD
12:40 pm Lunch
MULTIDISCIPLINARY APPROACH TO PATIENT OPTIMIZATION
Moderators: Jeff Hsu, MD, PhD and Darko Vucicevic, MD
2:00 pm The Patient Perspective
Mario Deng, MD, FACC, FESC and Cathy Levenstein, LCSW
2:30 pm Remote Monitoring in Advanced Heart Failure with CardioMEMS: Case Series
Daniel Cruz MD, PhD
2:50 pm Practical Tips on Implementing the Latest Heart Failure Therapies
Julie Creaser, RN, MN, CNS, CHFN and Anca Rahman, RN, MSN, NP-C
3:10 pm Cardio-oncology: A New Frontier for a Growing Patient Population
Eric Yang, MD, FACC, FASE
3:30 pm Wearables in AF: How do I Choose the Right Device?
Janet Han, MD, FACC, FHRS
3:50 pm Expanding Patient Access: Shared Care and Growing Collaboration with the Community
Melissa Moore, RN, MPH, CCTC and Aaron Kaye, RN, BSN, CCRN
4:00 pm Reception and Adjourn

At the conclusion of this program, participants will be able to:

  • Identify the epidemiology and pathophysiology of heart failure and the need for mechanical circulatory support with a growing heart failure population.
  • Identify indications for and management of lifelong left ventricular assist device therapy.
  • Implement shared care programs with the community and co-manage patients in need of complex cardiac therapies including LVAD therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous interventions, and complex congenital heart disease management.
  • Discuss the comprehensive multidisciplinary care and services available to complex cardiac patients within the UCLA Heart Failure Program.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The FDA issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.

Location

The Ritz-Carlton, Marina del Rey
4375 Admiralty Way
Marina Del Rey, CA 90292
(310) 823-1700

Conference Room

Salon 1 & 2 Ballroom

Parking

Valet Parking: $15